P
PT UBC Medical Indonesia Tbk
IDX:LABS
PT UBC Medical Indonesia Tbk
IDX:LABS
Price:
150
IDR
0.67%
Market Cap:
Rp592.5B
Balance Sheet
Balance Sheet Decomposition
PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk
Balance Sheet Decomposition is not available for
PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk
Balance Sheet
PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk
Currency: IDR
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
11 598
|
828
|
3 617
|
42 554
|
|
| Cash |
11 598
|
828
|
3 617
|
42 554
|
|
| Total Receivables |
7 438
|
17 015
|
33 326
|
19 585
|
|
| Accounts Receivables |
7 438
|
17 015
|
33 326
|
19 585
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
30 498
|
35 300
|
55 392
|
71 852
|
|
| Other Current Assets |
9 331
|
6 531
|
18 561
|
25 054
|
|
| Total Current Assets |
58 864
|
59 674
|
110 896
|
159 045
|
|
| PP&E Net |
31 041
|
25 000
|
36 104
|
33 452
|
|
| PP&E Gross |
31 041
|
25 000
|
36 104
|
33 452
|
|
| Accumulated Depreciation |
22 123
|
30 456
|
40 173
|
51 577
|
|
| Intangible Assets |
0
|
0
|
6 147
|
5 339
|
|
| Note Receivable |
0
|
9 185
|
0
|
338
|
|
| Long-Term Investments |
2 430
|
5 952
|
0
|
0
|
|
| Other Long-Term Assets |
2 659
|
8 919
|
7 140
|
5 426
|
|
| Total Assets |
94 994
N/A
|
108 730
+14%
|
160 287
+47%
|
203 599
+27%
|
|
| Liabilities | |||||
| Accounts Payable |
32 022
|
35 041
|
38 474
|
26 463
|
|
| Accrued Liabilities |
512
|
1 283
|
2 901
|
586
|
|
| Short-Term Debt |
0
|
18 563
|
21 322
|
23 973
|
|
| Current Portion of Long-Term Debt |
658
|
670
|
598
|
1 282
|
|
| Other Current Liabilities |
50 628
|
4 926
|
26 885
|
319
|
|
| Total Current Liabilities |
83 820
|
60 482
|
90 179
|
52 623
|
|
| Long-Term Debt |
416
|
297
|
639
|
1 805
|
|
| Minority Interest |
0
|
1
|
0
|
0
|
|
| Other Liabilities |
1 526
|
480
|
20 109
|
10 416
|
|
| Total Liabilities |
85 761
N/A
|
61 261
-29%
|
110 927
+81%
|
64 845
-42%
|
|
| Equity | |||||
| Common Stock |
11 432
|
46 837
|
46 837
|
79 000
|
|
| Retained Earnings |
2 755
|
79
|
2 269
|
5 221
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
54 157
|
|
| Other Equity |
555
|
554
|
254
|
376
|
|
| Total Equity |
9 232
N/A
|
47 470
+414%
|
49 360
+4%
|
138 755
+181%
|
|
| Total Liabilities & Equity |
94 994
N/A
|
108 730
+14%
|
160 287
+47%
|
203 599
+27%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
3 950
|
3 950
|
3 950
|
3 950
|
|
Switch to:
Switch to:
See Also
Discover More
